男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

中間α-球蛋白抑制因子H4(ITIH4)重組蛋白

Recombinant Inter Alpha-Globulin Inhibitor H4 (ITIH4)

IHRP; PK120; H4P; ITIHL1; Plasma Kallikrein-Sensitive Glycoprotein; Plasma kallikrein sensitive glycoprotein 120; Inter-alpha-trypsin inhibitor family heavy chain-related protein

  • 中間α-球蛋白抑制因子H4(ITIH4)重組蛋白產(chǎn)品包裝(模擬)
  • 中間α-球蛋白抑制因子H4(ITIH4)重組蛋白產(chǎn)品包裝(模擬)
  • RPH776Hu01.jpgSDS-PAGE圖
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

序列

用法

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

相關(guān)產(chǎn)品

編號適用物種:Homo sapiens (Human,人)應(yīng)用(僅供研究使用,不用于臨床診斷!)
APH776Hu01中間α-球蛋白抑制因子H4(ITIH4)活性蛋白Cell?culture;?Activity?Assays.
APH776Hu03中間α-球蛋白抑制因子H4(ITIH4)活性蛋白Cell?culture;?Activity?Assays.
RPH776Hu02中間α-球蛋白抑制因子H4(ITIH4)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPH776Hu03中間α-球蛋白抑制因子H4(ITIH4)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPH776Hu01中間α-球蛋白抑制因子H4(ITIH4)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAH776Hu03中間α-球蛋白抑制因子H4(ITIH4)多克隆抗體WB; IHC
PAH776Hu02中間α-球蛋白抑制因子H4(ITIH4)多克隆抗體WB; IHC; ICC; IP.
PAH776Hu01中間α-球蛋白抑制因子H4(ITIH4)多克隆抗體WB; IHC; ICC; IP.
FAH776Hu01抗中間α-球蛋白抑制因子H4(ITIH4)多克隆抗體FCM
FAH776Hu03抗中間α-球蛋白抑制因子H4(ITIH4)多克隆抗體FCM
LAH776Hu71中間α-球蛋白抑制因子H4(ITIH4)多克隆抗體(生物素標(biāo)記)WB; IHC; ICC.
MAH776Hu21中間α-球蛋白抑制因子H4(ITIH4)單克隆抗體WB; IHC; ICC; IP.
SEH776Hu中間α-球蛋白抑制因子H4(ITIH4)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMH776Hu中間α-球蛋白抑制因子H4(ITIH4)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
KSH776Hu01中間α-球蛋白抑制因子H4(ITIH4)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法)Main materials for "Do It (ELISA Kit) Yourself".

參考文獻(xiàn)

雜志參考文獻(xiàn)
Toxicology LettersBiomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.[Pubmed: 23830989]
International Journal of Medical MicrobiologyProteomic demonstration of the recurrent presence of inter-alpha-inhibitor H4 heavy-chain during aspergillosis induced in an animal model[Pubmed:24360996]
Cancer Research and TreatmentInter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma[pubmed:28724284]
DiagnosticsSystemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J[Pubmed: 32585848]
Liver CancerBiomarkers for locally advanced hepatocellular carcinoma patients treated with liver-directed combined radiotherapy[]